Chapter 22: The Female Genital Tract Pathology
Welcome to Last Minute Lecture.
This free chapter overview is designed to help students review and understand key concepts.
These summaries supplement not replaced the original textbook and may not be redistributed or resold.
For complete coverage, always consult the official text.
Welcome back to the Deep Dive.
Today we are, we're doing something a little bit different.
Usually we take a stack of articles, maybe some op -eds, and try to synthesize a worldview out of but today we are going heavy.
Oh, literally heavy.
I mean, it's a doorstop.
Yeah, exactly.
We are cracking open The Big Robins, the 11th edition of Robins, Cotran, and Kumar Pathologic Basis of Disease, the book that has induced scoliosis in generations of medical students.
It is the Bible of pathology.
There is really no other way to describe it.
Right.
And specifically, we are zooming in on chapter 22, which is the female genital tract.
Now before we start, I do want to set the ground rules for everyone listening.
Whether you are a medical student sweating over your boards right now, a resident, or just someone fascinated by human biology, this is a closed book session.
Yeah, and that's a really crucial distinction to make right up front because in the clinical world, guidelines change every single week.
You've got ACOG bulletins, you've got up -to -date protocols on how to actually treat these things.
Right, the clinical management.
Exactly.
But we are ignoring all of those today.
We are sticking religiously to the text of chapter 22.
So if Robins says it, we discuss it.
If it is not in the chapter, it does not exist for the next hour.
We are strictly here for the pathology, the mechanism, the morphology, the actual why behind the disease.
And we're going to do this logically.
We are walking the anatomical path.
Starting from the very beginning.
Right, starting with the embryology to set the stage, and then moving from the vulva up through the cervix and uterus, all the way to the ovaries, and finally the placenta.
It sounds like a really long journey, and it is, but there's a narrative here that you have to follow.
These organs aren't just separate boxes floating in the pelvis.
They share a developmental story.
And that story dictates how they get sick.
Exactly, it dictates the pathology.
So let's start exactly there.
Section one, embryology.
I feel like most people, myself included, usually just sort of skim or skip the embryology paragraph to get to the good stuff.
Like the cancer?
Oh, everybody does.
It's the same in nature.
Right, but looking at the notes here, Robbins actually flags this
common origin concept right at the start.
And it seems to explain a whole lot of what comes later.
It is completely fundamental.
Yeah.
If you skip this part, the ovarian tumor section later on becomes an absolute nightmare to memorize.
You're just memorizing random facts.
Okay, so ground us.
What are we looking at?
So if you look at figure 22 .1 in the text, it describes the interplay between the Malarian ducks.
Those are also called the Paramezonephric ducks, right?
Correct.
Paramezonephric ducks.
And it shows their interplay with the Wolfian or Mesonephric ducks.
Okay, so the Malarian ducks are kind of the main characters for the female tract.
They are.
They fuse together to form the fallopian tubes, the uterus, the cervix, and the upper part of the vagina.
But here is the big aha moment that the text really highlights.
The epithelial lining of this entire tract, along with the outer surface of the ovaries, they share a common origin from the Koalamic epithelium.
Also known as the mesothelium.
Exactly.
So wait, let me make sure I'm picturing this right.
The lining of the fallopian tube, which is inside the body and the outside surface of the ovary, they are basically cousins.
Siblings, really.
I mean, they are cut from the exact same cloth
embryologically.
And why does that matter so much for the pathology?
Because it explains why you see morphologically similar lesions in completely different places.
So you can get a cirrus tumor in the ovary, right?
Yeah.
But you can also get a cirrus tumor in the peritoneum or in the fallopian tube.
And they all look identical under a microscope.
Because they all come from that same mesothelial lineage.
Right.
You have the same developmental memory.
They remember what kind of tissue they're supposed to be.
That makes the classification of ovarian tumors make so much more sense later on.
They aren't just random buckets of diseases.
They are recapitulating their own history.
Exactly.
Now the text also mentions those Wolfian ducts you brought up.
In females, we usually learn that these just sort of degenerate because there is no Y chromosome driving them to become male structures.
They mostly degenerate.
Yeah.
But pathology is very often about the things that don't follow the rules.
So Robin specifically mentions these things called Gartner duct cysts.
Okay.
Gartner duct cysts.
That sounds like a board exam question waiting to happen for you guys listening.
Oh, it absolutely is.
So these are remnants of the mesonephric ducts, the male ducts.
And you might find them in the lateral walls of the cervix or the vagina.
Wait, so they're just sitting there.
Yeah.
They're basically fluid -filled ghosts of a male reproductive tract that never actually happened.
They just sit there.
They're usually totally asymptomatic.
Yeah.
But they prove that embryologic history.
Vestigial structures causing trouble.
That is a classic medical theme.
Always.
Okay.
Before we actually climb the anatomical ladder, we have to deal with the invaders.
Section two is infections.
And the text splits this into lower tract and upper tract.
So let's start low.
The lower general tract infections.
The text focuses on the big players here.
You got herpes, molluscum, fungi, and a few specific bacteria.
Let's hit herpes simplex virus first.
HSV.
Because the text paints a very specific and honestly a very painful clinical picture here.
It does.
It describes a strict progression.
It is not just, you know, you get a sore.
It starts as red papules.
Like little bumps.
Right.
Which then evolve into vesicles, which are these little fluid -filled blisters.
And then those vesicles break open to form coalescent ulcers.
And the key word that Robbins emphasizes over and over is painful.
Painful ulcers.
Yeah.
But the pathology isn't just happening on the skin surface, right?
The virus is doing something much deeper, which is the part that always kind of freaks me out.
That is the mechanism of latency.
HSV is a neurotropic virus.
It likes nerves.
So it doesn't just hang out in the skin.
It actually migrates up the sensory nerves to the regional lumbosacral nerve ganglia.
And it hides there.
It establishes latency.
It effectively goes to sleep right there in the nerve roots, completely shielded from your immune system.
Just waiting.
Waiting for a trigger.
Stress, sunlight, hormonal changes.
And then it wakes up, travels back down that exact same nerve, and causes a breakout on the skin.
Which explains the recurrence.
I mean, you can put an ointment on the ulcer and treat that, but you can't scrub the ganglia.
No, you can't.
It's there for good.
The text also raises a massive red flag about transmission to neonates.
Yes.
And this is incredibly high yield.
If a mother has an active infection during delivery, the risk to the infant is severe.
Because their immune system is brand new.
Exactly.
Neonatal herpes is a devastating systemic infection, and it's very often fatal.
That is why checking for active lesions is such a critical step in obstetrics.
Moving from viruses to fungi?
Candida.
The yeast.
Now, Robbins makes a really important point here to say that Candida is actually part of the normal vaginal microflora for many women.
So it's not always an invader from the outside?
No, it's an opportunist from within.
It's already there.
It's just waiting for a weakness in the defenses?
Correct.
The text lists the triggers.
Diabetes, antibiotics, pregnancy,
basically anything that disturbs the normal hormonal or bacterial ecosystem.
And what's the visual for this one?
The book says, curd -like vaginal discharge.
That is the classic textual descriptor you need to lock into your brain.
Curd -like.
Descriptive.
If slightly unappealing.
Okay, next up is trichomonas vaginalis.
Now this one is a protozoan.
It's a microscopic parasite.
And the text gives us a very different visual here.
It calls it the strawberry cervix.
I have always found that image so vivid.
But what is actually happening to the tissue to make it look like a piece of fruit?
Is it actively bleeding?
No, it's vascular dilation.
The infection causes a really marked dilation of the mucosal vessels in the cervix.
So when a doctor looks via a colposcopy, the cervix is fiery red, and it has these accentuated vascular spots all over it.
Oh, so the spots look like the seeds of a strawberry.
Exactly.
It looks just like the surface of a strawberry.
And finally, for the lower tract, we have Gardnerella vaginalis, which is the main culprit in bacterial vaginosis.
Right.
And here, the diagnosis is purely microscopic.
You're looking for something called clue cells.
Okay, break that down for us.
What exactly is a clue cell?
Okay, so imagine a normal squamous epithelial cell.
It's a big, flat, fried egg looking cell.
Got the fried egg in my head.
No, imagine the fried egg is completely covered in tiny little cuckoo bacilli bacteria.
The bacteria stick to the surface of the cell, and they obscure the clean borders of it, giving it this granular, kind of shaggy appearance.
So it looks dirty under the scope.
Yeah, that's a clue cell.
And clinically, the text notes this presents with a green -gray discharge that has a very characteristic fishy odor.
Okay, so that is the annoying but generally treatable bucket.
But then the text shifts gears pretty hard into pelvic inflammatory disease, or PID, and this feels much more consequential.
It is much more dangerous.
PID is an ascending infection.
It starts down in the vulva or the vagina, and it climbs up into the uterus, the tubes, and the ovaries.
And who are the main culprits here?
The two main organisms the text mentions are Neisseria, Gunneria, and Chlamydia.
The classics.
But Robbins makes a really fascinating distinction in how these specific bugs spread compared to other types of infections.
And this is a mechanism point that is very easy for students to miss.
I definitely missed it on my first read.
How do they differ?
So, a gynaecoccal infection typically spreads via the mucosal surfaces.
Like, along the lining?
Exactly.
Think of it as surfing the tract, moving steadily upward.
It sticks to the epithelium, and it climbs.
But you contrast that with what the book calls puerperal infections.
Infections that happen after a delivery or an abortion.
Right.
Those are often caused by things like Staphylococci or Streptococci.
And they don't surf.
No, they burrow.
They spread through the lymphatics and the venous channels deep within the actual walls of the organs.
Oh, wow.
Yeah.
So because of that, they tend to produce a lot more inflammation deeper in the layers of the uterus, like the myometrium and the perimetrium, rather than just sitting on the surface lining.
That is a crucial distinction for you listening.
Surface spread versus deep lymphatic spread.
Now, what does PID actually do when it reaches the Philippian tubes?
It causes massive destruction.
In the acute phase, you get hyperegnemia and edema.
The tube literally fills with pus.
This is called a piocell pinks.
Piocell pinks.
Pio meaning pus.
Cell pinks meaning tube.
Exactly.
But the real long -term damage happens when the body tries to heal from that.
The delicate little folds inside the tube, the plique, they get fused together by scarring.
And if the tube completely seals off.
Then the pus eventually absorbs, and it fills with clear fluid, instead becoming a hydrocell pinks.
Hydro meaning water.
Right.
And the consequences of this scarring are devastating.
The text lists infertility, severe intestinal adhesions, chronic pelvic pain.
But the scariest one is the ectopic pregnancy risk.
Absolutely.
The tube becomes this scarred, confusing dead -end maze,
and the fertilized egg just gets stuck there.
Can't make it to the uterus.
We are definitely going to touch on ectopics later in the gestational section.
But let's move to the anatomy proper now.
We are starting at the very bottom.
The vulva.
We have cysts, we have inflammation, and we have tumors.
What is the first thing that jumps out from the text?
Probably the Bartholin cyst.
It is a very common clinical problem.
Where is that exactly?
The Bartholin gland sits right down by the opening of the vagina.
And if the duct to that gland gets obstructed by inflammation, the gland doesn't know to stop working.
It just keeps secreting fluid.
So it just balloons out.
Exactly.
It forms a cyst, and the text says these can get up to 3 -5 cm in diameter.
That sounds incredibly uncomfortable.
It's very painful.
And very often they get secondarily infected and form an abscess.
But moving on to the skin itself.
The pathology of the actual vulva skin.
Robin spends a lot of time comparing two white lesions.
Lichen sclerosis and lichen simplex chronicus.
Right.
Now these sound similar.
They both look white to the naked eye, which the text broadly calls leukoplakia.
But the book is very clear that they are totally different entities with very different risks.
Let's distinguish them.
Let's start with lichen sclerosis.
Visually this looks like smooth white plaques.
The text uses the specific term parchment -like.
Because the epidermis is severely thinned out.
Parchment -like implies it's very fragile.
It is extremely fragile.
Microstopically the key feature here is a band -like lymphocytic infiltrate in the dermis right underneath that thin skin.
So the immune system is essentially attacking the skin.
Yes.
And the key takeaway for students here is that lichen sclerosis carries a slightly increased risk of developing squamous cell carcinoma later on.
It is considered a pre -malignant condition for some women.
Okay, so you really have to watch it.
Contrast that with lichen simplex chronicus.
This one is essentially the result of the itch -scratch cycle.
The patient has some sort of irritation.
They itch, they scratch it chronically, and the skin thickens up to protect itself.
Like forming a callus.
Exactly like a callus.
Morphologically you don't see thinning at all.
You see acanthesis, which is the pathological term for thickening of the epidermis, along with hyperkeratosis.
So one is thinned and parchment -like, that's sclerosis.
The other is thickened and leathery, that's chronicus.
You got it.
And for lichen simplex chronicus, the text explicitly implies there is no inherently increased cancer risk.
But because it looks like a white plaque, a leukoplakia,
you very often have to do a biopsy anyway, just to be absolutely sure it isn't something worse.
Speaking of something worse, we have to talk about vulvar tumors.
Specifically, condyloma ecumenatum.
Genital warts.
Right.
These are sexually transmitted,
and they are almost always caused by HPV type 6 and 11.
And Robbins refers to these as low -risk HPV.
Low -risk meaning they very rarely turn into invasive cancer.
They are annoying, they are unsightly, but they aren't malignant.
Now the microscopic buzzword here, and this is a word you and listeners are going to hear a lot today, is coelacitic atypia.
Yes, we are going to hear coelacite over and over.
Paint a picture for us.
If you are looking through the microscope, what does a coelacite actually look like?
It is the absolute hallmark of an HPV -infected scroma cell.
The nucleus becomes enlarged, and it becomes a hyperchromatic.
Meaning very dark.
Dark and kind of wrinkly, like a raisin.
And crucially, there is a clear, empty -looking halo all the way around that dark nucleus.
So it looks like a raisin sitting in a clear little bubble inside the cell.
The raisin in a bubble.
That is a perfect way to remember it.
I love a good visual.
Now when we talk about actual vulvar carcinoma, real cancer, the text describes two completely different pathways to getting there.
And this was actually new to me when I was reviewing the chapter.
I just assumed all vulvar cancer was HPV -driven.
No, and that is a critical distinction in Robbins that you have to know.
Pathway 1 is the HPV -associated pathway.
This closely mirrors what we see in the cervix.
Okay.
It usually affects younger women, very often smokers.
And it is linked to high -risk HPV types, specifically 16 and 18.
It starts as a precursor lesion called VIN, vulvar intrapathelial neoplasia, and then it progresses.
And under the microscope.
These tumors often look basiloid or warty.
Okay, so what is pathway 2?
Pathway 2 is the non -HPV pathway.
It typically affects older women, and it arises in the setting of long -standing lichensclerosis.
That parchment skin we just talked about.
Exactly.
And crucially, the driver here isn't a viral hijacker.
It is a genetic mutation in the TP53 tumor suppressor gene.
So one is viral, affecting younger women, and the other is genetic or inflammatory, affecting older women.
That is a really fascinating split.
It's a classic dual pathway disease.
Before we leave the vulva entirely, there is one more weird condition mentioned.
Extramammary Paget disease.
Yes.
This one presents as a pruritic, red, crusted, map -like area, usually on the labia majora.
Pruritic, meaning itchy.
But wait, we hear the name Paget, and we immediately think of breast cancer, right?
Paget disease of the breath.
Right.
And in the breast, Paget disease of the nipple is almost always a sign that there is an underlying invasive ductal carcinoma working deeper in the breast tissue.
The cancer cells are literally crawling up the milk ducts to the skin surface.
And I'm guessing this is the big but in the text.
It is.
In the vulva, Paget disease is usually strictly intrapathelial.
It arises right there in the epidermis of the skin itself.
It does not usually have an underlying invasive cancer associated with it.
So the prognosis is generally much better than the breast equivalent.
Generally, yes.
It can be very persistent and really annoying to treat locally, but it's not a death sentence like an underlying undetected breast cancer might be.
And what do these cells look like?
Microscopically, you see these large tumor cells with very pale cytoplasm.
These are the Paget cells.
And they're sitting right there in the epidermis, either singly or in little clusters.
The text mentions they have a halo, too, which can make distinguishing them from a superficial melanoma really important for the pathologist.
But that's getting a little into the weeds.
A bit, yeah.
OK, let's move up the canal.
The vagina.
Usually, at least in my head, the vagina is just sort of a conduit for disease that's spreading either down from the cervix or up from the vulva.
But it does have a few of its own specific issues in this chapter.
It does.
There are congenital anomalies, for instance, like a septate vagina.
What causes that?
That happens when the malurian ducts are failed to fuse completely during embryogenesis.
And this is very often accompanied by a double uterus as well.
And then there is the DES story, vaginal adenosis.
This is a historical tragedy, but it teaches us so much about embryology in tissue zones.
Women who are exposed to diethylstilbestrol, or DES, in utero, meaning their mothers,
took this drug during pregnancy to prevent miscarriage back in the mid -20th century.
These women developed patches of glandular columnar epithelium in the vagina.
But the vagina is supposed to be lined with squamous epithelium, right?
Like tough, skin -like tissue to handle friction.
Exactly.
But these women had glandular tissue, which looks red and granular to the naked eye.
It's almost like the mucosal tissue for the inside of the uterus got lost during development and ended up taking root in the vagina.
And I know they don't use DES anymore, obviously.
Right, it's rare to see new cases now.
But it is a classic pathology lesson, because that misplaced glandular tissue carries a small, but very real risk of developing a very rare cancer later on, clear cell adenocarcinoma.
And speaking of rare cancers, the text mentions a very specific malignancy for children in the vagina.
Embryonal rhabdomia sarcoma, also known historically as sarcoma motrioids.
Otrioids, that is the key buzzword there.
It literally means grape -like.
Grossly, when you look at it, this tumor looks like a polypoid, bulky mass resembling a bunch of grapes protruding from the vagina.
It is absolutely terrifying, because it primarily happens in infants and very young children under five.
God, that's awful.
What do we see under the microscope to diagnose it?
Two really unique things.
First, something called the cambium layer.
Like in a tree trunk?
Similar concept, yeah.
This is a very crowded zone of tumor cells that congregate right beneath the vaginal epithelium.
The cells condense there.
And second, the cells themselves are rhabdomial blasts.
Primitive muscle cells.
Yes, they are sometimes strap -shaped or they look like little tennis rackets.
And if you look really, really closely at high power, they may even show cross -deraiations.
Because they are trying to differentiate into skeletal muscle.
Exactly, they are trying, but failing.
Tennis rackets and grapes.
Pathology really does love a grocery store analogy.
Okay, moving up to the gatekeeper,
the cervix.
The cervix.
This is public -held enemy number one in this chapter.
It is all about one specific anatomic location, the transformation zone.
Okay, define that for us.
Why is this specific zone so vulnerable to disease?
It is the battleground between two completely different cell types.
The endocervix, the inner canal going up to the uterus, is lined by fragile columnar cells.
But the ectocervix, the outer part facing the vagina, is lined by tough squamous cells.
And where they meet is the squamous columnar junction.
Exactly, now as women age or due to the natural acidity in the vagina, those fragile columnar cells undergo squamous metaplasia.
They literally change their shape and type to turn into tougher squamous cells to protect themselves.
This dynamic, constantly changing area of metaplasia is the transformation zone.
And the virus just absolutely loves this zone.
The immature basal cells in this exact transformation zone are the specific primary target for human papillomavirus,
HPV.
Okay, let's go incredibly deep on HPV because the text doesn't just say it causes cancer.
It explains the exact molecular mechanism.
It's not just that the virus infects the cell and kills it, it actually hijacks the cell's internal control center.
It is brilliant and insidious.
The high -risk HPV types integrate their DNA into the host cell's genome and they produce two viral oncoproteins that you absolutely must know for any exam, E6 and E7.
I always, always get these two mixed up.
Let's draw them right now.
E6 targets what?
E6 targets P53.
Okay, remember P53 is the guardian of the genome.
Right, normally if a cell has DNA damage, P53 senses it and stops the cell from dividing so it can fix the damage or tells the cell to commit suicide.
Apoptosis, E6 binds directly to P53 and promotes its rapid degradation via the ubiquitin pathway.
It tags the guardian for the molecular trash can.
Exactly, it throws the guardian in the trash.
So the cell completely loses its emergency breath.
And what about E7?
E7 targets the retinoblastoma protein, RB.
Now RB normally puts the brakes on the cell cycle at a very specific point, the G1 to S phase checkpoint.
E7 binds to RB and displaces the transcription factors, specifically E2F that RB was holding onto.
Which effectively releases the brakes on cell division.
Yes, so E6 takes away the emergency stop button by killing P53 and E7 slams down on the gas pedal by inhibiting RB.
That is just a perfect awful recipe for uncontrolled growth and massive genomic instability.
It is.
Now we know that most HPV infections don't actually become cancer.
The immune system handles them.
The text distinguishes between the precursor lesions, LSIL and HSI.
LSIL, which stands for low -grade squamous intrapathelial lesion, corresponds to what we used to call CINI.
This is essentially a productive viral infection.
The virus is just using the cell to make more of itself.
This is where you see those choilocytes we talked about earlier, the raisin in a bubble.
Yes, tons of choilocytes.
But the host immune system usually wins this battle.
Most LSILs regress completely spontaneously.
And HSI.
I -grade cell.
This corresponds to CIM2 or 3.
Here, the virus isn't just replicating.
It is fully integrated into the host DNA.
It creates total deregulation of the cell cycle.
What does that look like pathologically?
Morphologically, you see massively increased cellular proliferation.
You see a loss of maturation, meaning the cells don't get flatter and wider as they move up toward the surface like they're supposed to.
And they have very high nuclear to cytoplasmic ratio.
They're all nucleus, no body.
Right, these dark angry cells are crowding the entire epithelium.
And HSIL has a very high risk of progressing to actual invasive carcinoma if it isn't treated.
And when it does become invasive cervical carcinoma, where does it go?
The text mentions a specific cause of death that I found incredibly surprising.
It wasn't metastasis to the brain or the liver, like you see with a lot of cancer.
It's renal failure.
Renal failure from a cervical cancer.
Yes, and it is purely based on local anatomy.
The cervix is sitting right next to the ureters, which are the tubes carrying urine from the kidneys down to the bladder.
And advanced invasive cervical carcinoma can extend directly out into the surrounding pelvic soft tissue and physically compress or completely block those ureters.
Wow.
This causes hydronephrosis, massive fluid swelling of the kidneys, and eventually post -renal kidney failure.
It is a very common terminal event in untreated cases.
That is a very sobering anatomical correlation.
And of course, the text mentions the PAP test as the primary screening tool to catch these lesions at the LSIL or HSIL stage long before they ever invade and hit the ureters.
Absolutely.
The PAP smear is arguably the most successful cancer screening test in the history of medicine.
It relies on gently scraping those cells from the transformation zone and looking for the coelocytes or the high -grade dysplasia under the microscope.
All right, moving on to section six, the uterine corpus, the main body of the uterus.
We have the endometrium, which is the inner lining, and the myometrium, which is the thick muscle wall.
Let's start with the lining.
The endometrium is incredibly dynamic tissue.
It physically grows and sheds every single month in a cycle.
But things can easily go wrong with that cycle.
The text talks a lot about dysfunctional uterine bleeding, which is very often caused by inovulatory cycles.
A novulatory meaning no ovulation, so no egg is released, which means no progesterone is produced, right?
Exactly.
The corpus luteum in the ovary never forms, so there's no progesterone.
So what happens is you get unopposed estrogen stimulation.
And estrogen makes the lining grow.
Right.
The endometrium just stays in the proliferative phase.
It grows too thick, too fast, and eventually it structurally breaks down because it literally outgrows its own blood supply.
This causes random, often heavy bleeding.
Robbins notes this is especially common at monarch, when periods are just starting, and at menopause when they're ending.
What about inflammation of the lining?
Endometritis.
You can have acute endometritis, which is usually a bacterial infection right after a delivery or a miscarriage.
But chronic endometritis is much trickier for a pathologist.
The diagnosis strictly relies on finding one specific cell type in the endometrial stroma.
Which cell?
The plasma cell.
Oh, interesting.
Yeah, you normally have lymphocytes there, but you should never see plasma cells in a normal endometrium.
If you see them, it is automatically chronic endometritis.
It's often associated with prior PID, retained gestational tissue, or having an IUD.
Okay, now let's tackle the two sister conditions that sound identical but are completely different.
Adenomyosis and endometriosis.
They sound alike because they both involve misplaced endometrial tissue, but the location is the absolute key.
Endomyosis is the presence of endometrial tissue deep within the myometrium.
Inside the actual uterine muscle wall.
Yes, it causes the uterine wall to thicken dramatically.
The text describes the uterus as becoming enlarged and globular.
Clinically, it causes menorrhagia, which is heavy bleeding, and severe dysmenorrhea or pain.
And endometriosis.
This is endometrial tissue that is implanted completely outside the uterus.
You can find it on the ovaries, the uterine ligaments, the pouch of Douglas, even scattered across the abdominal peritoneum.
The text lists a few theories for how it actually gets all the way out there.
Because it shouldn't be there.
The regurgitation theory is definitely the most favored one right now.
This is the idea of retrograde menstruation.
So instead of all the menstrual blood flowing down and out through the cervix, some of it flows backward, up through the fallopian tubes, and it spills out and implants into the abdominal cavity.
But there is also the metaplasia theory, right?
That the abdominal lining just spontaneously decides to turn into uterine lining.
Correct.
And remember that common origin concept we spent so much time on in the intro, this is exactly where it comes back.
The coelomic epithelium, the mesothelium lining the abdomen,
has the latent potential to differentiate into endometrium because they share that exact same embryologic lineage.
It's all connected.
Now the morphology of endometriosis is very distinct, especially in the ovaries.
It is.
Because this ectopic tissue, wherever it is, it still cycles in response to hormones just like the normal uterus does.
So every month it bleeds.
But the blood has absolutely nowhere to exit the body.
In the ovary, this old trapped blood accumulates over time to form large cystic masses filled with thick brown fluid.
The famous chocolate cysts.
Exactly, endometriomas.
Elsewhere in the pelvis, you might see what the book calls gunpowder burns, which are these little black fibrotic nodules.
Or you might just see extensive fibrous adhesions gluing organs together.
It is a major, major cause of infertility in chronic pelvic pain.
Now we have to talk about endometrial hyperplasia and endometrial cancer.
This is a massive section in the chapter.
Hyperplasia is the precursor state.
It is driven by prolonged unopposed estrogen stimulation.
So things like obesity, because peripheral fat tissue literally converts precursors into estrogen or chronic anovulation or exogenous estrogen therapy.
The genetics here strongly involve the inactivation of the PTN tumor suppressor gene.
And then the text divides actual carcinoma of the endometrium into two highly distinct types,
type I and type II.
This is a massive high -yield board distinction.
Let's break down type I first.
Type I is the endoletreoid type.
It accounts for the vast majority of cases, around 80%.
What's the typical patient profile?
Usually peri -menopausal women, very often obese, or with a known history of that hyperplasia we just mentioned.
And the main driver?
Unopposed estrogen.
The genetics.
PTN mutations are the classic early event here.
And what does it look like?
Morphologically, it looks glandular.
It actually closely resembles normal endometrium, just growing out of control.
And the prognosis is generally quite good because it usually causes abnormal bleeding early on, so it gets caught early.
Okay, now contrast that with type II, because this one is the bad actor.
Type II is the psoriasis type.
Patient profile.
Older post -menopausal women.
And the driver.
This is key.
It arises in the setting of endometrial atrophy, not hyperplasia.
Estrogen has absolutely nothing to do with it.
And the genetics.
TP53 mutations.
Once again, our old friend P53 appears when things get aggressive.
And morphology.
It forms these complex papillary structures, and it is high grade by definition.
So type I is estrogen, obesity, and PTN.
Type II is atrophy, thin, and P53.
That is a very clean mental split to remember.
It is, and you have to know it.
Before we completely leave the uterus, we have to touch on the muscle tumors, the myometrium, fibroids.
Leomyomas.
They are benign, smooth muscle tumors.
And they're incredibly common.
They might actually be the most common humor in women overall.
Grossly, if you cut into one, they are firm gray -white, and they have this very distinct world cut surface, like a cross section of a golf ball.
But how does a pathologist tell a completely benign fibroid from a highly malignant leomyosarcoma?
The text is very specific, that you can't just look at how big it is.
No, science does not dictate malignancy here.
You have to look at the tissue under the microscope and look for three very specific criteria.
Okay, what are they?
One, tumor necrosis.
Is the tissue dying in the center?
Two, cytologic atypia.
Do the individual cells look wild and weird?
And three, the mitotic index.
How fast are they dividing?
Right.
If you see 10 or more mitosis per high -power field, along with that atypia and necrosis, you are dealing with a sarcoma.
And sarcomas are usually single, solitary masses in post -menopausal women, whereas benign fibroids are very often multiple and occur during the reproductive years.
Correct.
And crucially, there's a big point.
Robin states that sarcomas do not arise from pre -existing fibroids.
They arise de novo from scratch.
So having fibroids doesn't mean you have a ticking time bomb that's gonna turn into a sarcoma.
That's a very reassuring point.
All right, let's head to the ovaries.
Section seven, now this organ seems to have the absolute most diverse set of tumors in the entire human body.
It is a complete zoo in this section.
It really is.
It can be overwhelming, but to understand them, you just have to look at the simple microscopic anatomy of the ovary itself.
It has three distinct components, and each component gives rise to its own class of tumors.
One, the surface epithelium, that's the outer covering.
Two, the germ cells, those are the eggs themselves.
And three, the sexchord stroma.
Those are the supporting cells around the eggs, like the granulosa and the sminka cells.
So if you know the cell of origin, you know the tumor class.
Exactly.
Let's start with the non -neoplastic stuff first, though.
The cysts.
Very common, follicular and luteal cysts.
They're basically just normal ovarian follicles that either didn't rupture to release the egg, or didn't seal up properly after they did.
They're entirely physiological.
And what about PCOS, polycystic ovarian syndrome?
This is a highly complex endocrine disorder, not just a physical cyst problem.
The ovaries show multiple subcapsular cysts and something called stromal hyperthicosis, which is a thickening of the ovarian stroma.
And clinically, how does that present?
These patients typically have oligomeria, irregular periods.
They often have hirsutism, excess hair growth, because that thickened stroma produces excess androgens.
And they very frequently struggle with obesity and severe insulin resistance.
Okay, let's get into the actual tumors.
Group one, the surface epithelial tumors.
These are the most common malignant ones, right?
Yes, by far.
And the most common subtype within this group is the cirrus tumor.
These are cystic tumors filled with clear, watery cirrus fluid.
The text splits the malignant ones into low grade and high grade.
What's the genetic difference?
Low grade is usually associated with KRAS or BRAF mutations.
High grade is associated with TP53 mutations.
Now, there is a really interesting, relatively new note in the text about where high grade cirrus carcinoma actually comes from.
Yes, this is a major paradigm shift in pathology.
The current evidence suggests that a huge percentage of high grade cirrus carcinomas of the ovary actually originate from the fimbriae of the Philippian tube.
Not the ovary itself.
No, they start as precursor lesions in the tube called estic cirrus tubal intratheleal carcinomas.
These lesions shed malignant cells, which fall onto the surface of the ovary, implant there, and then grow into the massive tumor we eventually find.
So the ovary is essentially just the innocent bystander, the soil for the seed.
Exactly, it's wild.
And genetically,
these high grade tumors have a very strong link to BRCA1 and BRCA2 inherited mutations.
And under the microscope, what is the buzzword for cirrus tumors?
Somomabodies.
These are concentric, laminated calcifications.
They look exactly like little layered grains of sand sitting in the tissue.
What about the next subtype, the mucinous tumors?
These are large, multi -loculated cysts filled with thick, sticky gelatinous mucin.
They're usually driven by KRAS mutations.
And the text mentions a specific clinical condition here called pseudomyxoma peritone.
Also famously known as jelly belly?
Yes.
But the text clarifies something really important about jelly belly, right?
If you see it, you shouldn't just assume it's from the ovary.
Right, if you open the abdomen and it is filled with massive amounts of mucin, the primary tumor is actually usually in the appendix, not the ovary.
The ovary is just involved secondarily by metastasis.
So pathologists know, always check the appendix.
Fascinating.
And the endometrioid ovarian tumors?
These microscopically look just like endometrial glands, hence the name.
And they're very often associated with underlying endometriosis.
They also share that PTN mutation link with regular uterine cancer.
And finally for this group, the Brenner tumor.
Just a rare oddity.
Yeah.
It is composed of transitional epithelium.
So under the microscope, it looks bizarrely like the lining of the bladder, but it is usually benign.
Okay, moving to group two.
The germ cell tumors.
This is where things get really weird.
Yes, starting with the teratoma.
Okay, break this down.
Mature versus immature.
A mature teratoma, also called a dermoid cyst, is mostly benign.
It contains fully mature tissues derived from all three embryologic germ layers.
You open it up and you see?
Hair, teeth, sebum, skin, sometimes thyroid tissue.
It is like a disorganized little monster.
And the immature teratoma.
These are malignant.
And the key defining feature that makes it immature and dangerous is the presence of immature neuroepithelium.
Fetal brain tissue.
Yes.
If a pathologist sees primitive fetal brain tissue in there, that indicates it is malignant and aggressive.
Got it.
Then there's the dysgerminoma.
This is the female exact equivalent of the male testicular seminoma.
It is a solid tumor.
It has a known link to Turner syndrome.
And the really good news is that it is exquisitely radio sensitive.
And the yolk sac tumor.
Also called an endodermal sinus tumor.
Clinically, it produces very high levels of alpha -fetoprotein or AFP in the blood.
And the microscopic buzzword.
Schiller -Deval bodies.
They're these intricate little structures that look exactly like primitive kidney glomeruli under the microscope.
Group three.
The sexchord stromal tumors.
These are the ones that actively secrete hormones which drives the symptoms.
Exactly.
First is the granulosa cell tumor.
It secretes high levels of estrogen.
So in a young child, that massive estrogen hit causes precocious puberty.
In an older post -menopausal woman, it causes the uterine lining to grow leading to abnormal bleeding and potentially endometrial hyperplasia.
What's the buzzword here?
Called exner bodies.
They're these small gland -like follicles filled with pink acidophilic material.
What about the fibroma?
Benign tumors of fibroblasts.
But they are famous for a specific clinical triad called Meg's syndrome.
Right.
Ovarian fibroma plus a site's fluid in the abdomen plus hydrothorax fluid around the lungs.
Yes.
And the amazing, almost magical thing about Meg's syndrome is that if you surgically remove the benign ovarian tumor,
the massive fluid accumulations in the chest and belly just spontaneously resolve on their own.
That is incredible.
And the Sertoli -Ledig cell tumor?
These cells recapitulate normal testicular tissue.
So they produce androgens like testosterone.
The female patient presents with masculinization or virilization, deepening voice, hair growth.
And grossly, if you cut the tumor open, it is bright golden yellow because of all the lipids stored inside Ledig cells to make those steroid hormones.
Finally, to wrap up the ovaries, we have to talk about metastatic tumors coming from outside.
The text specifically highlights the Kruckenberg tumor.
This is a classic, classic board choice.
A Kruckenberg tumor is a bilateral metastasis to both ovaries, and the primary source is almost always a gastric carcinoma, a stomach cancer.
And what do the cells look like?
Signet ring cells.
They're these big tumor cells completely filled with a huge droplet of mucin, which pushes the nucleus all the way to the very edge of the cell, making it look like a signet ring you'd wear on your finger.
We are in the final stretch here, section eight, gestational and placental pathology.
Let's start with ectopic pregnancy.
This is implantation of the fertilized ovum anywhere outside the normal uterine cavity.
90 % of the time, that happens in the fallopian tubes.
And the huge risk here.
Rupture of the tube and massive, life -threatening intraperitoneal hemorrhage.
It is an absolute medical emergency.
And tying it all back, the cause is very often what we talked about an hour ago.
Prior chronic salpingitis from PID.
It scarred the tube, destroyed those delicate folds, and physically trapped the egg.
Moving to placental abnormalities.
The text compares placenta previa and placenta accreta.
It's all about location and depth.
Placenta previa is when the placenta implants way too low, directly over or right next to the cervical loss.
As the cervix starts to stretch in the third trimester, it tears the placenta, causing painless but severe bleeding.
And accreta.
Accreta is a depth problem.
The placenta implants too deeply.
It adheres directly into the myometrium, the muscle wall, because the normal intervening layer of decidua is missing.
And the danger is at delivery, right?
Yes.
Because it's anchored into the muscle, it completely fails to separate naturally after the baby is born.
This leads to massive, catastrophic postpartum hemorrhage when they try to deliver it.
Let's talk about preeclampsia.
This is obviously a huge, complex topic in obstetrics, but what is the specific pathological mechanism that Robbins describes here?
Clinically, it's a systemic syndrome.
Hypertension, proteinuria, and edema in the mother.
Robbins proposes the root cause is fundamentally maternal endothelial dysfunction, and it's driven entirely by the placenta.
How does the placenta do that?
The stress placenta releases circulating factors into the mother's blood that actively antagonize normal vessel growth.
Specifically, it releases something called SFLT1.
Soluble FMS like tyrosine kinase 1.
Right, and this SFLT1 binds directly to VEGF, vascular endothelial growth factor, and neutralizes it.
So it steals the VEGF.
Yes.
And without active VEGF, the mother's endothelium everywhere in her body suffers in dysfunctions, leading to the high blood pressure in the leaky kidneys.
And if you look at the placenta itself.
Morphologically, it looks terrible.
You see multiple infarcts, retroplacental hematomas, and major abnormalities in how the maternal spiral arteries formed.
It's a failing organ.
And finally, the last major topic,
gestational trophoblastic disease,
the moles.
How did you form moles?
These are essentially massive genetic accidents during fertilization.
Let's split them up.
Complete mole first.
A complete mole has a 46XXX karyotype.
But here's the crazy part.
All of that DNA is paternal.
It all comes from the dad.
What happens is an empty egg, an egg with no maternal chromosomes, gets fertilized by one sperm that duplicates its DNA, or by two sperms.
So there's no mom DNA at all.
Does a fetus form?
No, no fetal parts ever develop.
Morphologically, all of the chorionic villi become massively swollen and edematous.
They look like a giant cluster of grapes.
And clinically.
The patient has a positive pregnancy test with extremely high HCG levels.
But on ultrasound, instead of a baby, the doctor sees a classic snowstorm appearance.
And importantly, a complete mole carries a significant risk of developing into chorio carcinoma.
Okay, now the partial mole.
A partial mole is usually triploid, 69 ,000 XXY.
This happens when two normal sperm fertilize one normal egg.
So there is maternal DNA here.
Yes, because of that, some fetal parts may actually be present, though they aren't viable.
Morphologically, only some of the villi are swollen, while others look normal.
And the cancer risk later on is much, much lower.
But if things do go malignant, we arrive at chorio carcinoma.
Yes, this is a highly, highly aggressive malignant tumor of the placental trophoblasts.
What's the key morphologic feature?
The key is what it does not do.
It does not form villi at all.
It is just solid, wild sheets of cytotrophoblasts,
and satietrophoblasts deeply invading the uterine muscle and immediately invading the blood vessels.
And because it hits the blood vessels, it spreads fast.
Very fast.
Early hematogenous spread, especially to the lungs and the brain.
But the text notes a massive silver lining here.
It does.
Despite being one of the most rapidly aggressive cancers we know of,
it is remarkably, almost miraculously sensitive to chemotherapy.
Wow.
Yeah, the cure rate is nearly 100%, even if the patient already has widespread metastasis in her lungs or brain.
It is genuinely one of the greatest success stories in all of medical oncology.
Wow, that was a lot.
I mean, from the microscopic clucell all the way to the massive grape -like sarcomas, and from the viral molecular mechanics of HPV, E6, and E7 to the hormonal storms of the ovary.
It is an incredibly complex system, but the patterns really do hold up.
The embryologic origins, the hormonal influences, the specific pathways of infection, they make it understandable.
If you remember that the ovary and the uterus share that mesothelial lining, or that HPV directly attacks P53 and RB, the rest of the memorization just falls right into place.
So what does this all mean for you, the listener?
It means that when you look at these diseases, whether for a test or in a clinic, don't just blindly memorize the name of the tumor.
Look for the mechanism.
Yes, exactly.
Ask yourself, is this driven by P53 or PTE -N?
Is the spread mucosal surfing or lymphatic burrowing?
Is the origin the service epithelium or the germ cell?
If you anchor yourself in the anatomy and the why, the diagnosis logically follows.
And I wanna leave you with one final thought that kind of struck me while we were talking about the placenta at the very end.
The trophoblast cells of a normal placenta, their entire biological job is to aggressively invade the uterine wall and hijack the maternal blood supply.
They act exactly like a metastatic cancer, but evolution has designed the female body to perfectly control and halt that invasion right where it needs to stop.
It's only when that control breaks down that we get something like choreocarcinoma.
It really blurs the line between a miraculous physiological function and a deadly pathology.
That's a great point.
And if you have the book in front of you, take a moment to look at figure 22 .11, the sarcoma boteroids and the gross images of the teratoma.
The visual pathology is truly unforgettable.
Thank you so much for sticking with us on this very heavy deep dive into chapter 22.
Good luck with your studies and your boards.
From the last minute lecture team, thank you for listening.
See you in the next deep dive.
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.
Support LML ♥Related Chapters
- Sexually Transmitted InfectionsLewis's Medical-Surgical Nursing: Assessment and Management of Clinical Problems
- Sexually Transmitted InfectionsPathophysiology: The Biologic Basis for Disease in Adults and Children
- Female Genital PathologyUSMLE Step 1 Lecture Notes 2017: Pathology
- Gestational Complications & High-Risk PregnancyPerry's Maternal Child Nursing Care in Canada
- Promoting Reproductive Health: Sexually Transmitted DiseasesDavis Advantage for Maternal-Child Nursing Care
- Sexually Transmitted Infection Drug TherapyPharmacology: A Patient-Centered Nursing Process Approach